[ Centogene AG raises $27.99M in Series A funding ]

Centogene AG has raised $27.99 million in Series A funding.

Founded in 2006, Centogene AG  is a worldwide leader in the field of genetic diagnostic testing for rare hereditary diseases, with a broad test portfolio covering over 2800 genes, biochemical tests, biomarker and clinical whole exome sequencing and whole genome sequencing.

The proceeds of the financing will be used to accelerate the company’s further growth and expansion plans in the business segments of worldwide Genetic Testing, Pharmaceutical Collaborations and Big Data-Solutions.

Funding  Series A
Founded  2006
Country  Germany
City  Rostock, Mecklenburg-  Vorpommern
Founder / CEO  Joachim Schindler
Deal Size  $27.99M
Investors  CIC Capital
 TVM Capital Life Science
 Careventures,
 DPE Deutsche Private Equity
Previous Investors  /